Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H16N5S |
Molecular Weight | 334.418 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
CC1=C(C)N=C(S1)[N+]2=NC(=NN2C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=FTZIQBGFCYJWKA-UHFFFAOYSA-N
InChI=1S/C18H16N5S/c1-13-14(2)24-18(19-13)23-21-17(15-9-5-3-6-10-15)20-22(23)16-11-7-4-8-12-16/h3-12H,1-2H3/q+1
Molecular Formula | C18H16N5S |
Molecular Weight | 334.418 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16216776
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776
Thiazolyl Blue is a membrane-permeable yellow dye that is reduced by mitochondrial reductases in living cells to form the dark blue product. The net positive charge on Thiazolyl Blue appears to be the predominant factor involved in their cellular uptake via the plasma membrane potential. Thiazolyl Blue is used as a direct indicator of cytotoxicity (such as for screening cancer drugs), proliferation and apoptosis. Thiazolyl Blue is also an electron acceptor used for studying NADP-dependent dehydrogenases. Thiazolyl Blue reduction is associated not only with mitochondria, but also with the cytoplasm and with nonmitochondrial membranes including the endosome/lysosome compartment and the plasma membrane. Biological Applications: cell viability assay; microbial growth assays; DNA quantification assays; tissue viability assays; detecting enzymes; measuring membrane potential; treating Alzheimer’s disease, asthma, cancer. Because Thiazolyl Blue forms an insoluble formazan it has usually been applied in endpoint assays.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Succinate dehydrogenase Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776 |
|||
Target ID: Oxidoreductases Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:55:18 GMT 2023
by
admin
on
Sat Dec 16 10:55:18 GMT 2023
|
Record UNII |
010O4LC9TS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
13146-93-5
Created by
admin on Sat Dec 16 10:55:18 GMT 2023 , Edited by admin on Sat Dec 16 10:55:18 GMT 2023
|
PRIMARY | |||
|
53233
Created by
admin on Sat Dec 16 10:55:18 GMT 2023 , Edited by admin on Sat Dec 16 10:55:18 GMT 2023
|
PRIMARY | |||
|
DTXSID701202933
Created by
admin on Sat Dec 16 10:55:18 GMT 2023 , Edited by admin on Sat Dec 16 10:55:18 GMT 2023
|
PRIMARY | |||
|
64966
Created by
admin on Sat Dec 16 10:55:18 GMT 2023 , Edited by admin on Sat Dec 16 10:55:18 GMT 2023
|
PRIMARY | |||
|
010O4LC9TS
Created by
admin on Sat Dec 16 10:55:18 GMT 2023 , Edited by admin on Sat Dec 16 10:55:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |